Found 0 matching trials
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
PHASE2This research study is testing whether a weekly medication called tirzepati...
Location
Institut de Recherches Cliniques de Montréal
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
PHASE2This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury
PHASE1Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Location
Chinese PLA General Hospital
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
NAThis is a Prospective, Multicenter, Randomized Controlled study to evaluate...
Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, Hubei, P. R. China
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
PHASE3RATIONALE: Providing information that is tailored to answer patients' quest...
Location
Barbara Ann Karmanos Cancer Institute
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
PHASE2Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Location
Fudan University Shanghai Cancer Center
CIBMTR Research Database
N/AThe primary purpose of the Research Database is to have a comprehensive sou...
Location
Center for International Blood and Marrow Transplant Research
Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies
NAThis clinical trial examines sustained oral fiber supplementation for patie...
Location
Fred Hutch/University of Washington Cancer Consortium
Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy
PHASE2The trial is designed as a multi-center, open label Phase 2 trial that inve...
Location
3203; Antwerp University Hospital; Department of Medical Oncology
Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments
PHASE2This Phase IIB, multicenter, double-blind, randomized, and uncontrolled cli...
Location
Multiple Locations